Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Enliven Therapeutics (ELVN) Non-cash Items (2019 - 2025)

Enliven Therapeutics has reported Non-cash Items over the past 7 years, most recently at $5.0 million for Q4 2025.

  • Quarterly results put Non-cash Items at $5.0 million for Q4 2025, down 92.76% from a year ago — trailing twelve months through Dec 2025 was $5.0 million (down 92.76% YoY), and the annual figure for FY2025 was $5.0 million, up 46.26%.
  • Non-cash Items reached $5.0 million in Q4 2025 per ELVN's latest filing, down from $69.2 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $69.2 million in Q4 2024 and bottomed at $9000.0 in Q2 2022.
  • Median Non-cash Items over the past 5 years was $3.8 million (2021), compared with a mean of $11.8 million.
  • The largest annual shift saw Non-cash Items tumbled 99.77% in 2022 before it skyrocketed 2889.28% in 2023.
  • Over 5 years, Non-cash Items stood at $9.7 million in 2021, then plummeted by 87.64% to $1.2 million in 2022, then surged by 2889.28% to $35.7 million in 2023, then surged by 93.86% to $69.2 million in 2024, then plummeted by 92.76% to $5.0 million in 2025.
  • Business Quant data shows Non-cash Items for ELVN at $5.0 million in Q4 2025, $69.2 million in Q4 2024, and $35.7 million in Q4 2023.